BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10344357)

  • 21. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished erythropoietin-induced erythroid growth in patients with renal anemia is restored by recombinant human erythroid differentiation factor.
    Shimizu T; Kawano Y; Takaue Y; Kuroda Y
    Am J Hematol; 1994 Nov; 47(3):178-82. PubMed ID: 7942781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
    Borrego FJ; Miguel JL; Zamorano A; Muñoz J; Bajo A; López-Revuelta K; Sánchez Sicilia L
    Med Clin (Barc); 1991 Nov; 97(18):687-92. PubMed ID: 1770818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin.
    Göbel V; Hoffmann HG; Müller-Wiefel DE; Braun A; Ludwig R; Schärer K; Debatin KM
    Eur J Pediatr; 1994 Jan; 153(1):43-8. PubMed ID: 8313924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of monocyte-macrophage colony-stimulating factor (M-CSF) on in vitro erythropoiesis of marrow progenitor cells from patients with renal anemia.
    Kawano Y; Takaue Y; Minakuchi J; Kawashima S; Kimura F; Motoyoshi K; Abe T; Sato J; Hirao A; Saito S
    Eur J Haematol; 1995 Mar; 54(3):147-52. PubMed ID: 7720833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
    Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA
    Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
    Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
    Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous.
    Hörl WH
    Acta Haematol; 1992; 87 Suppl 1():16-9. PubMed ID: 1574961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E; Kaeser U
    Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.
    Yaqoob M; Ahmad R; McClelland P; Shivakumar KA; Sallomi DF; Fahal IH; Roberts NB; Helliwell T
    Postgrad Med J; 1993 Feb; 69(808):124-8. PubMed ID: 8506193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating burst-forming unit-erythroid (BFU-E) colonies as an early marker to measure the recombinant human erythropoietin response in peritoneal dialysis patients.
    Castro MA; Fernandez de Castro M; Selgas R; Fernandez-Reyes MJ; Bajo MA; Jimenez C; Del Peso G; Dapena F; de Alvaro F
    Adv Perit Dial; 1996; 12():66-70. PubMed ID: 8865876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.
    Van Damme-Lombaerts R; Broyer M; Businger J; Baldauf C; Stocker H
    Pediatr Nephrol; 1994 Jun; 8(3):338-42. PubMed ID: 7917862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
    Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y
    Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC
    Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
    Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
    Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.